CDSCO Releases Draft Standard Evaluation Protocols For Issuing License For IVDs
New Delhi: The Central Drugs Standard Control Organisation (CDSCO) and Indian Council of Medical Research (ICMR) have together released the draft standard evaluation protocols for the purpose of issuing license for in-vitro…
CDRI Research A Ray Of Hope For Triple Negative Breast Cancer Patients
Lucknow: In a ray of hope for patients of triple negative breast cancer (TNBC), the scientists have found that administration of a drug on a specific enzyme found in the…
Licences of 36 TN drug stores revoked
Chennai: The Tamil Nadu drug control administration has revoked the licences of 36 retailers and wholesalers across the state for selling habit-forming drugs, opioid-based formulations used for anxiety or pain…
Dabur India expects low single-digit revenue growth in Q3
Dabur India on Friday said it expects to garner “low single-digit growth” in terms of consolidated revenue during the December quarter and a “flattish” operating profit growth. The company also…
Pharma teachers faking profiles at multiple institutions, face being blacklisted
New Delhi: In what has alarmed the government, the Pharmacy Council of India (PCI) has found widespread data faking on the government’s DIGI-PHARMed portal for teachers. As many as 45,355…
Sun Pharma sells entire stake in Japanese arm to Zaza Industrial Holdings
Sun Pharmaceutical Industries has announced the 100 per cent sale of its step-down subsidiary, Sun Pharma Japan Technical Operations, to Zaza Industrial Holdings K.K., Japan. The decision marks a strategic…
Bliss GVS Pharma Reaches 52-Week High of Rs. 181.35 with 42.53% Annual Return
Bliss GVS Pharma, a small-cap player in the pharmaceuticals and drugs industry, has recently reached a new 52-week high of Rs. 181.35 on January 1, 2025. The stock has shown…
















